Your institution may have access to this item. Find your institution then sign in to continue.
Title
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.
Authors
Kesselheim, Aaron S; Myers, Jessica A; Avorn, Jerry
Abstract
The Orphan Drug Act incentivizes medication development for rare diseases, offering substantial financial benefits to the manufacturer. Orphan products constitute most new drug approvals in oncology, but safety and efficacy questions have emerged about some of these agents.